PCK 3.33% 2.9¢ painchek ltd

FDA De Novo approval date for Painchek's Dementia App, page-8

  1. 584 Posts.
    lightbulb Created with Sketch. 121
    LBT have a high cost device which scans Agar plates and they had a huge amount of trouble selling this in Australia. The FDA approval gave it a huge jump the other month in price, but whether it sells is another question.

    PCK shouldn't have issues with market acceptance due to the value it provides, and what has developed over the past year.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.